Streetbeat News

Analyst Ratings

AIG

BMO Capital analyst Michael Zaremski maintains an Outperform rating on American International Group (AIG) and raises the price target from $87 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 3:33 pm

BMRN

RBC Capital analyst Luca Issi maintains a Sector Perform rating on Biomarin Pharmaceutical (NASDAQ:BMRN) but lowers the price target from $85 to $80.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 3:32 pm

VRTX

RBC Capital analyst Brian Abrahams maintains a Sector Perform rating on Vertex Pharmaceuticals (NASDAQ:VRTX) but lowers the price target from $431 to $425.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 3:27 pm

SRPT

RBC Capital has maintained its 'Outperform' rating on Sarepta Therapeutics and slightly raised the price target from $181 to $182.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 3:25 pm

PBF

BMO Capital has downgraded PBF Energy from Outperform to Market Perform and reduced its price target from $42 to $35.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 3:23 pm

IMAX

Rosenblatt analyst Steve Frankel maintains a Buy rating on Imax (NYSE:IMAX) with a $28 price target.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 3:23 pm

ZM

Rosenblatt analyst Catharine Trebnick maintains a Buy rating on Zoom Video Communications (NASDAQ:ZM) with a price target of $78.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 3:19 pm